Suchergebnisse - "Prins, Jan M"

PubPharm (8)

1

High level of virological suppression among HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa, Ethiopia

enthalten in: Antiviral therapy | 2016

von Mekuria, L. | Nieuwkerk, P. | Yalew, A. | +2

2

No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia

enthalten in: Antiviral therapy | 2012

von Grijsen, M. | Holman, R. | Gras, L. | +6

3

Selection of an M184V mutation in the cerebrospinal fluid of a treatment-naive HIV-infected individual starting darunavir-based therapy

enthalten in: Antiviral therapy | 2011

von Cornelissen, M. | Back, N. | Burger, D. | +4

4

Self-reported adherence is more predictive of virological treatment response among patients with a lower tendency towards socially desirable responding

enthalten in: Antiviral therapy | 2010

von Nieuwkerk, P. | de Boer-van der Kolk, I. | Prins, J. | +2

5

A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitor

enthalten in: Antiviral therapy | 2007

von Vermeulen, J. | Meijer, D. | Over, J. | +6

6

Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection

enthalten in: Antiviral therapy | 2006

von Locadia, M. | van Grieken, R. | Prins, J. | +3

7

Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection

enthalten in: Antiviral therapy | 2003

von Sankatsing, S. | van Praag, R. | van Rij, R. | +5

8

Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen

enthalten in: Antiviral therapy | 2002

von van Rij, R. | van Praag, R. | Prins, J. | +4

1
[1]